MannKind Corp
MNKD
$4.18
Share price
-0.24%
Change (1 day)
5.56%
Change (1 year)
Categories
EPS for MannKind Corp (MNKD)
EPS in 2023 (TTM): -$0.19
According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.34 a decrease over its 2021 EPS that were of -$0.32.
EPS history for MannKind Corp from 2004 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.19 | -44.12% |
| 2022 | -$0.34 | 6.25% |
| 2021 | -$0.32 | 28% |
| 2020 | -$0.25 | -7.41% |
| 2019 | -$0.27 | -55.74% |
| 2018 | -$0.61 | -45.05% |
| 2017 | -$1.11 | -188.1% |
| 2016 | $1.26 | -128.31% |
| 2015 | -$4.45 | 74.51% |
| 2014 | -$2.55 | -20.31% |
| 2013 | -$3.20 | -32.63% |
| 2012 | -$4.75 | -28.03% |
| 2011 | -$6.60 | -12% |
| 2010 | -$7.50 | -27.54% |
| 2009 | -$10.35 | -30.3% |
| 2008 | -$14.85 | -18.85% |
| 2007 | -$18.30 | -19.03% |
| 2006 | -$22.60 | 56.94% |
| 2005 | -$14.40 | -21.74% |
| 2004 | -$18.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -1,078.95% | 🇺🇸 USA |
 Novo Nordisk NVO | $2.86 | -1,603.03% | 🇩🇰 Denmark |
 Eli Lilly LLY | $5.43 | -2,957.52% | 🇺🇸 USA |
 Merck MRK | $1.82 | -1,058.78% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.74 | -1,015.79% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -$1.63 | 757.89% | 🇺🇸 USA |